Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-020743
Filing Date
2009-04-15
Accepted
2009-04-15 16:31:49
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v146005_10k.htm 10-K 3861065
2 v146005_ex10-62.htm EX-10.62 81687
3 GRAPHIC sig.jpg GRAPHIC 4084
4 v146005_ex10-63.htm EX-10.63 79833
5 v146005_ex10-64.htm EX-10.64 44104
6 v146005_ex10-65.htm EX-10.65 46363
7 v146005_ex10-66.htm EX-10.66 74975
8 v146005_ex10-67.htm EX-10.67 87704
9 v146005_ex23.htm EX-23 298
10 GRAPHIC v146005_ex23x22x1.jpg GRAPHIC 67455
11 v146005_ex31-1.htm EX-31.1 16073
12 v146005_ex32-1.htm EX-32.1 8043
  Complete submission text file 0001144204-09-020743.txt   4400431
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-33393 | Film No.: 09751422
SIC: 2834 Pharmaceutical Preparations